Skip to main content
Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
7.92
-0.26 (-3.18%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Xilio Therapeutics Revenue

In the year 2025, Xilio Therapeutics had annual revenue of $43.77M with 589.88% growth. Xilio Therapeutics had revenue of $13.69M in the quarter ending December 31, 2025, with 693.85% growth.

Revenue (ttm)
$43.77M
Revenue Growth
+589.88%
P/S Ratio
1.05
Revenue / Employee
$575,868
Employees
76
Market Cap
45.80M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202543.77M37.42M589.88%
Dec 31, 20246.34M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Radiopharm Theranostics 10.86M
Plus Therapeutics 5.21M
Nutriband 2.28M
Rallybio 858.00K
Hyperion DeFi 813.46K
Mereo BioPharma Group 500.00K
Revenue Rankings

XLO News

More News